AnalystsDavid NierengartenDavid Nierengarten's Stock Forecasts
AnalystsDavid Nierengarten
Sectors:
Industries:
Analyst Ranking
Top 3%
#120 out of 4587 analysts
Average Return
+20.65%
Win Rate
51%74 out of 145
Risk vs Reward
Poor
Good
David Nierengarten's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Anaptysbio IncANAB | +405.93% | $23.10 | $116.87 | 2017-03-08 - 2018-03-09 | Buy |
Fusion Pharmaceuticals IncFUSN | +382.46% | $4.39 | $21.18 | 2023-06-27 - 2024-03-19 | Buy |
Beam Therapeutics IncBEAM | +300.96% | $23.02 | $92.30 | 2020-03-01 - 2021-03-02 | Buy |
Fate Therapeutics IncFATE | +291.11% | $22.94 | $89.72 | 2020-04-02 - 2021-02-26 | Buy |
Karyopharm Therapeutics IncKPTI | +287.27% | $4.40 | $17.04 | 2019-02-26 - 2020-01-17 | Buy |
David Nierengarten Analyst Color
Get additional color on David Nierengarten's coverage of popular stocks
David Nierengarten's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nuvalent IncNUVL | 3 | Buy | $99.00 | +39.67% | Reiterates | 3 days ago |
Nuvation Bio IncNUVB | 4 | Buy | $5.00 | +50.60% | Reiterates | 5 days ago |
Sutro Biopharma IncSTRO | 6 | Buy | $8.00 | +99.50% | Reiterates | 6 days ago |
Ikena Oncology IncIKNA | 3 | Buy | $8.00 | +459.44% | Reiterates | 6 days ago |
Generation Bio CoGBIO | 7 | Buy | $5.00 | +36.61% | Reiterates | 6 days ago |
Anaptysbio IncANAB | 9 | Buy | $34.00 | +35.62% | Reiterates | 10 days ago |
Vor Biopharma IncVOR | 7 | Buy | $11.00 | +507.73% | Reiterates | 10 days ago |
Xencor IncXNCR | 6 | Buy | $36.00 | +56.32% | Maintains | 10 days ago |
Fate Therapeutics IncFATE | 12 | Hold | $5.00 | +28.21% | Maintains | 10 days ago |
Blueprint Medicines CorpBPMC | 2 | Buy | $110.00 | +4.80% | Reiterates | 24 days ago |
Tscan Therapeutics IncTCRX | 3 | Buy | $10.00 | +11.36% | Reiterates | a month ago |
Prime Medicine IncPRME | 3 | Buy | $12.00 | +69.49% | Reiterates | a month ago |
Intellia Therapeutics IncNTLA | 4 | Hold | $29.00 | +10.60% | Reiterates | a month ago |
Beam Therapeutics IncBEAM | 3 | Buy | $57.00 | +131.52% | Reiterates | a month ago |
Argenx SeARGX | 11 | Buy | $521.00 | +42.42% | Reiterates | a month ago |
Immunome IncIMNM | 3 | Buy | $33.00 | +138.61% | Maintains | 2 months ago |
Fusion Pharmaceuticals IncFUSN | 5 | Hold | $24.00 | +11.58% | Reiterates | 2 months ago |
Bluebird Bio IncBLUE | 1 | Hold | $1.68 | +63.11% | Maintains | 2 months ago |
2seventy Bio IncTSVT | 7 | Hold | $5.00 | +4.17% | Reiterates | 2 months ago |
Oric Pharmaceuticals IncORIC | 4 | Buy | $20.00 | +118.34% | Reiterates | 2 months ago |
Mersana Therapeutics IncMRSN | 2 | Buy | $7.00 | +156.41% | Upgrades | 3 months ago |
Springworks Therapeutics IncSWTX | 2 | Buy | $70.00 | +56.11% | Maintains | 3 months ago |
Cogent Biosciences IncCOGT | 2 | Hold | $10.00 | +34.41% | Maintains | 3 months ago |
G1 Therapeutics IncGTHX | 6 | Buy | $4.00 | -11.70% | Maintains | 3 months ago |
Inozyme Pharma IncINZY | 4 | Buy | $15.00 | +226.09% | Reiterates | 4 months ago |
Kinnate Biopharma IncKNTE | 4 | Hold | $2.00 | -24.53% | Reiterates | 4 months ago |
Kiniksa Pharmaceuticals LtdKNSA | 1 | Buy | $25.00 | +26.45% | Maintains | 5 months ago |
Maxeon Solar Technologies LtdMAXN | 5 | Hold | $5.00 | +69.49% | Maintains | 5 months ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Hold | $5.00 | -22.84% | Downgrades | 7 months ago |
Iteos Therapeutics IncITOS | 2 | Buy | $33.00 | +82.83% | Reiterates | 7 months ago |
Chimerix IncCMRX | 2 | Buy | $6.00 | +507.29% | Reiterates | 9 months ago |
Scholar Rock Holding CorpSRRK | 5 | Buy | $24.00 | +92.15% | Reiterates | 9 months ago |
Apogee Therapeutics IncAPGE | 1 | Buy | $40.00 | -20.49% | Initiates Coverage On | 9 months ago |
Karyopharm Therapeutics IncKPTI | 5 | Hold | $4.00 | +247.83% | Maintains | 10 months ago |
Theseus Pharmaceuticals IncTHRX | 2 | Buy | $7.00 | +72.41% | Maintains | 10 months ago |
Avrobio IncAVRO | 1 | Hold | $2.00 | +43.88% | Downgrades | 10 months ago |
Novocure LtdNVCR | 4 | Hold | $46.00 | +109.19% | Upgrades | a year ago |
Y Mabs Therapeutics IncYMAB | 2 | Buy | $13.00 | N/A | Upgrades | a year ago |
Iveric Bio IncISEE | 3 | Hold | $40.00 | N/A | Downgrades | a year ago |
Disc Medicine IncIRON | 2 | Buy | $36.00 | N/A | Maintains | a year ago |
Applied Genetic Technologies CorpAGTC | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Fennec Pharmaceuticals IncFENC | 3 | Buy | $19.00 | N/A | Maintains | 2 years ago |
Codiak Biosciences IncCDAKQ | 2 | Strong Buy | $7.00 | N/A | Maintains | 2 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Turning Point Therapeutics IncTPTX | 1 | Hold | $76.00 | N/A | Downgrades | 2 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Hold | $11.00 | N/A | Downgrades | 3 years ago |
Myokardia IncMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 4 years ago |
Stemline Therapeutics IncSTML | 3 | Hold | $12.50 | N/A | Downgrades | 4 years ago |
Syros Pharmaceuticals IncSYRS | 3 | Hold | $90.00 | N/A | Downgrades | 4 years ago |
Tesaro IncTSRO | 3 | Hold | $75.00 | N/A | Downgrades | 5 years ago |
Spark Therapeutics IncONCE | 2 | Hold | $40.00 | N/A | Upgrades | 6 years ago |
Ultragenyx Pharmaceutical IncRARE | 6 | Buy | $88.00 | N/A | Maintains | 6 years ago |
Audentes Therapeutics IncBOLD1 | 1 | Buy | $52.00 | N/A | Maintains | 6 years ago |
Endocyte IncECYT | 3 | Buy | $21.00 | N/A | Maintains | 6 years ago |
Voyager Therapeutics IncVYGR | 2 | Buy | N/A | N/A | Upgrades | 6 years ago |
Prothena Corp Public Ltd CoPRTA | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Kite Pharma IncKITE | 2 | Hold | N/A | N/A | Upgrades | 7 years ago |
Juno Therapeutics IncJUNO | 1 | Buy | N/A | N/A | Upgrades | 7 years ago |
Clementia Pharmaceuticals IncCMTA | 1 | Buy | $26.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.